Clene Inc. and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease using bioenergetic nanocatalysis, announced that Rob Etherington, President and Chief Executive Officer, will present at the Raymond James Human Health Innovation Conference on Tuesday, June 22, 2021 at 11:20 a.m. ET.
June 15, 2021
· 1 min read